Inventor · disambiguated record
Howard Welgus
Also filed as: WELGUS HOWARD · WELGUS HOWARD G · WELGUS HOWARD GLENN
11 granted patents·9 pending applications·40 citations·filing 1995–2025
87Inventor score
Files withARCUTIS BIOTHERAPEUTICS INC4VERRICA PHARMACEUTICALS INC4AMGEN INC3WARNER LAMBERT CO3BEELEY NIGEL ROBERT ARNOLD2
Top patents by PatentIndex Score
20 records- 0197US11992480B2Method for reducing side effects from administration of phosphodiesterase-4 inhibitorsARCUTIS BIOTHERAPEUTICS INC·Filed 2021·Granted May 28, 2024·8 cites·43 claims
- 0291US11147790B2Treatment of cutaneous disordersVERRICA PHARMACEUTICALS INC·Filed 2018·Granted Oct 19, 2021·5 cites·14 claims
- 0372US7189747B2Method of treating noninflammatory cartilage damageWARNER LAMBERT CO·Filed 2003·Granted Mar 13, 2007·5 cites·4 claims
- 0472US6620829B2Method of treating noninflammatory cartilage damageWARNER LAMBERT CO·Filed 2001·Granted Sep 16, 2003·3 cites·6 claims
- 0572US2025090509A1Methods of reducing itch using topical roflumilast compositionsARCUTIS BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0672US2025090508A1Methods of reducing itch using topical roflumilast compositionsARCUTIS BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0769US12233042B2Treatment of cutaneous disordersVERRICA PHARMACEUTICALS INC·Filed 2021·Granted Feb 25, 2025·0 cites·20 claims
- 0867US6800732B2Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of sameAMGEN INC·Filed 2001·Granted Oct 5, 2004·3 cites·1 claims
- 0965US2025332393A1Devices and methods for the treatment of body surface disordersVERRICA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1065US2024307388A1Formulations for substituted 3-pyrrolidines, compositions containing, and uses of sameLIPIDIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1162US2020155524A1Method for reducing side effects from administration of phosphodiesterase-4 inhibitorsARCUTIS INC·Filed 2019·Application pending·0 cites
- 1261US2021161870A1Roflumilast formulations with an improved pharmacokinetic profileARCUTIS BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1356US12290651B2Devices and methods for the treatment of body surface disordersVERRICA PHARMACEUTICALS INC·Filed 2018·Granted May 6, 2025·0 cites·20 claims
- 1450US11865113B2Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)LIPIDIO PHARMACEUTICALS INC·Filed 2017·Granted Jan 9, 2024·0 cites·9 claims
- 1550US6211209B1Method of inhibiting connective tissue degradationWARNER LAMBERT CO·Filed 1998·Granted Apr 3, 2001·14 cites·44 claims
- 1639US2018118707A1Beta-naphthoisoflavones, compositions containing, and uses of, sameTHESAN PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1738US2018179174A112H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAMEBEELEY NIGEL ROBERT ARNOLD·Filed 2016·Application pending·0 cites
- 1834US6342374B1Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of sameAMGEN INC·Filed 1999·Granted Jan 29, 2002·1 cites·4 claims
- 1933US6090585AHuman collagenase inhibitor sequence, recombinant vector system for using same and recombinant-DNA method for the manufacture of sameAMGEN INC·Filed 1995·Granted Jul 18, 2000·1 cites·8 claims
- 2032US2018185325A112H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAMEBEELEY NIGEL ROBERT ARNOLD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Howard Welgus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →